Evidence map›Paper›PMID 40761430›Full record

ReviewTherapeutic advances in urology

Artificial intelligence and radiomics applications in adrenal lesions: a systematic review.

Matteo Ferro, Octavian Sabin Tataru, Giuseppe Carrieri, Gian Maria Busetto, Ugo Giovanni Falagario, Martina Maggi, Felice Crocetto, Biagio Barone, Francesco Del Giudice, Michele Marchioni and 15 more

Abstract readReview
In one paragraph

Review in Therapeutic advances in urology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Matteo FerroUnit of Urology, Department of Health Science, ASST Santi Paolo and Carlo, University of Milan, Milan, Italy.ORCID https://orcid.org/0000-0003-4687-7353
Octavian Sabin TataruI.O.S.U.D., George Emil Palade University of Medicine, Pharmacy, Sciences, and Technology of Târgu Mureș, Gheorghe Marinescu Street, 38, Târgu Mureș 540142, Romania.ORCID https://orcid.org/0000-0001-7057-7815
Giuseppe CarrieriDepartment of Urology and Organ Transplantation, University of Foggia, Foggia, Italy.
Gian Maria BusettoDepartment of Urology and Organ Transplantation, University of Foggia, Foggia, Italy.ORCID https://orcid.org/0000-0002-7291-0316
Ugo Giovanni FalagarioDepartment of Urology and Organ Transplantation, University of Foggia, Foggia, Italy.
Martina MaggiDepartment of Maternal Infant and Urologic Sciences, "Sapienza" University of Rome, Policlinico Umberto I Hospital, Rome, Italy.
Felice CrocettoDepartment of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.
Biagio BaroneDivision of Urology, Department of Surgical Sciences, AORN Sant'Anna e San Sebastiano, Caserta, Italy.
Francesco Del GiudiceDepartment of Maternal Infant and Urologic Sciences, "Sapienza" University of Rome, Policlinico Umberto I Hospital, Rome, Italy.
Michele MarchioniUnit of Urology, Department of Medical, Oral and Biotechnological Sciences, SS. Annunziata Hospital, Chieti, Italy.
Daniela TerraccianoDepartment of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.
Giuseppe LucarelliUnit of Urology, Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
Pasquale DitonnoUnit of Urology, Andrology and Kidney Transplantation, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy.
Raul GherasimDepartment of Urology, George Emil Palade University of Medicine, Pharmacy, Sciences, and Technology of Târgu Mureș, Târgu Mureș, Romania.
Ciprian Todea-MogaDepartment of Urology, George Emil Palade University of Medicine, Pharmacy, Sciences, and Technology of Târgu Mureș, Târgu Mureș, Romania.
Giuseppe FallaraDivision of Urology, European Institute of Oncology (IEO)-IRCCS, Milan, Italy.
Marco TozziUnit of Urology, Department of Health Science, ASST Santi Paolo and Carlo, University of Milan, Milan, Italy.
Antonio CioffiDepartment of Urology, Ospedale del Mare, Napoli, Italy.
Roberto BianchiDivision of Urology, European Institute of Oncology (IEO)-IRCCS, Milan, Italy.
Alessio DigiacomoDepartment of Urology, Azienda Ospedaliera Universitaria Integrata of Verona, University of Verona, Verona, Italy.
Alessandro VecciaDepartment of Urology, Azienda Ospedaliera Universitaria Integrata of Verona, University of Verona, Verona, Italy.
Alessandro AntonelliDepartment of Urology, Azienda Ospedaliera Universitaria Integrata of Verona, University of Verona, Verona, Italy.
Maria Chiara SighinolfiDepartment of Urology, Agostino Gemelli Hospital Foundation-IRCCS, Catholic University Medical School, Rome, Italy.
Luigi SchipsUnit of Urology, Department of Medical, Oral and Biotechnological Sciences, SS. Annunziata Hospital, Chieti, Italy.
Bernardo RoccoDepartment of Urology, Agostino Gemelli Hospital Foundation-IRCCS, Catholic University Medical School, Rome, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Adrenal lesions, often incidentally detected, present diagnostic challenges in distinguishing benign from malignant or hormonally active lesions. Conventional imaging (computed tomography/magnetic resonance imaging (CT/MRI)) has limitations, driving interest in artificial intelligence (AI) and radiomics for enhanced accuracy. Objectives: To systematically evaluate AI and radiomics applications in adrenal lesion characterization, focusing on diagnostic performance, methodologies, and clinical utility. Design: PRISMA-guided systematic review of studies published up to June 2024. Data sources and methods: PubMed, Scopus, Web of Science, and Google Scholar were searched using the keywords: Results: CT-based radiomics (eight studies) achieved a mean AUC of 0.88 (range: 0.84-0.94) in differentiating benign/malignant or functional/non-functional lesions. Top-performing models identified aldosterone-producing adenomas (AUC: 0.99). MRI-based radiomics (three studies) yielded mean AUC: 0.82 (0.72-0.92), with test-set performance declines (e.g., AUC: 0.72) suggesting overfitting. Nuclear medicine (four studies) demonstrated that hybrid 18F-FDG PET/CT models (SUVmax + texture features) achieved an AUC of 0.97 for metastatic versus benign lesions. AI applications extended to intraoperative navigation (AUC: 0.93) and prognostic prediction. Conclusion: CT-based radiomics outperformed MRI, aligning with guidelines favoring CT for adrenal assessment. AI-enhanced models show promise in refining diagnostics and reducing invasive procedures. However, retrospective designs, small cohorts, and protocol variability limit generalizability. Future work requires multicenter collaboration, standardized protocols, and prospective validation to translate AI/radiomics into clinical practice.

Indexed as

adrenal tumorsartificial intelligencecomputed tomographymagnetic resonance imagingradiomics

Identifiers

PMID40761430
PMCPMC12319203

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.